Thyrocare Technologies Limited provides diagnostic testing services to patients, laboratories, and hospitals in India. It operates in three segments: Diagnostic Testing Services, Imaging Services, and Others. The company conducts various medical diagnostic tests and profiles of tests that focuses on early detection and management of disorders and diseases, including thyroid, growth, metabolism, auto-immunity, diabetes, anaemia, cardiovascular, infertility, COVID, and various infectious diseases. Its profiles of tests include 34 profiles of tests administered under its Aarogyam brand, which offers patients a suite of wellness and preventive health care tests. The company also sells glucometer and glucostrips under the brand name Sugarscan; consumables; and radiopharmaceutical. Thyrocare Technologies Limited was founded in 1996 and is based in Navi Mumbai, India. Thyrocare Technologies Limited is a subsidiary of Docon Technologies Private Limited.
Thyrocare Technologies Dividend Announcement
• Thyrocare Technologies announced a annually dividend of ₹18.00 per ordinary share which will be made payable on 2024-09-22. Ex dividend date: 2024-08-16
• Thyrocare Technologies annual dividend for 2024 was ₹18.00
• Thyrocare Technologies annual dividend for 2023 was ₹18.00
• Thyrocare Technologies's trailing twelve-month (TTM) dividend yield is 1.79%
• Thyrocare Technologies's dividend growth over the last five years (2018-2023) was 12.47% year
Thyrocare Technologies Dividend History
Ex-Div date | Dividend amount | Dividend type | Pay date |
---|---|---|---|
2024-08-16 | ₹18.00 | annually | 2024-09-22 |
2023-04-20 | ₹18.00 | annually | 2023-04-29 |
2022-05-11 | ₹15.00 | annually | 2022-05-29 |
2021-06-17 | ₹15.00 | annually | 2021-07-26 |
2020-11-12 | ₹10.00 | annually | 2020-11-27 |
2019-11-21 | ₹5.00 | annually | 2019-12-07 |
2019-08-14 | ₹20.00 | annually | 2019-09-23 |
2018-08-02 | ₹5.00 | annually | 2018-09-10 |
2018-02-15 | ₹5.00 | annually | 2018-03-05 |
2017-08-03 | ₹5.00 | annually | 2017-09-11 |
2017-02-08 | ₹5.00 | annually | 2017-02-27 |
2016-09-01 | ₹2.50 | annually | 2016-10-12 |
Thyrocare Technologies Dividend per year
Thyrocare Technologies Dividend growth
Thyrocare Technologies Dividend Yield
Thyrocare Technologies current trailing twelve-month (TTM) dividend yield is 1.79%. Interested in purchasing Thyrocare Technologies stock? Use our calculator to estimate your expected dividend yield:
Thyrocare Technologies Financial Ratios
Thyrocare Technologies Dividend FAQ
Other factors to consider when evaluating Thyrocare Technologies as a dividend stock include its dividend yield, dividend growth, payout ratio, and the sustainability of its dividend payments given its earnings and cash flow. These factors can provide insight into the company's ability to maintain or increase its dividend in the future.
Place an order: Use the brokerage's trading platform to place an order to buy Thyrocare Technologies stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.
1. Determination of Dividend: Thyrocare Technologies's board of directors reviews the company's financial performance, cash flow, future investment needs, and other relevant factors to determine the amount and timing of dividend payments.
2. Dividend Declaration: Once the board approves a dividend, Thyrocare Technologies publicly announces the dividend amount, currency, and the ex-dividend date. The ex-dividend date is the date on or after which the buyer of the stock will not be eligible to receive the upcoming dividend payment.
3. Record Date: The record date is the date on which the company checks its records to identify shareholders who are eligible to receive the dividend. Only shareholders on record as of this date will receive the dividend.
4. Payment Date: On the designated payment date, Thyrocare Technologies distributes the dividend to eligible shareholders. The dividend is usually paid in the form of cash directly into the shareholder's brokerage account or through other designated payment methods.
5. Tax Implications: Dividends received from Thyrocare Technologies are generally taxable as income. Shareholders may need to report dividend income on their tax returns and pay applicable taxes according to their jurisdiction's tax regulations.
1. Record Date: Thyrocare Technologies sets a record date, which is the date on which the company checks its records to determine the eligible shareholders. Only those who are shareholders on record as of this date will receive the dividend.
2. Payment Date: On the designated payment date, Thyrocare Technologies distributes the dividend to eligible shareholders. The payment is usually made electronically, directly into the shareholder's brokerage account or bank account.
3. Currency: Thyrocare Technologies declares the currency in which the dividend will be paid. Depending on the shareholder's location and the currency election made by the shareholder, the dividend will be converted to the appropriate currency during the payment process.
To assess the safety of Thyrocare Technologies's dividend, it is crucial to analyze the company's financial health, debt levels, cash flow generation, and ability to sustain dividend payments over the long term. Additionally, monitoring the company's future earnings, cash flow projections, and management's commitment to dividend policies can provide valuable insights.
It is recommended to review Thyrocare Technologies's financial reports, official announcements, and consult with financial advisors or experts who have access to the most current and comprehensive information about the company's financial situation.